California has entered a 10-year contract with nonprofit drugmaker Civica Rx to manufacture insulin and cap costs at $30 per vial, Gov. Gavin Newsom announced during a March 18 press conference. 

Mifepristone, which was approved by the FDA in 2000 for use in ending early term pregnancies, has been banned by Wyoming Gov. Mark Gordon ahead of a federal ruling on the drug pending in a Texas court. 

At least five states have introduced legislation this year to cap patients’ out-of-pocket costs for EpiPens and other generic epinephrine autoinjectors. 

Amgen, a drugmaker based in Thousand Oaks, Calif., will lay off 450 people — 2 percent of its workforce — with many separations occurring by May 26, according to a statement shared with Becker’s. 

At least four oncology drugs are in shortage, and some drugmakers don’t expect supply levels to recover until mid-2023. 

The shortage of a drug approved just shy of one year ago by the FDA to treat prostate cancer is now in limited supply, concerning some physicians.

Pfizer recalled more than 4 million packets of Nurtec, a migraine prescription drug, on March 16 because the container is not child resistant. 

Amid the ongoing shortage of local anesthetic drugs, the FDA has drafted new guidance for drugmakers, which could eventually help curb the supply issues.

Michigan Medicine will use Zipline’s new drones to deliver prescriptions to patients’ doors, which will “more than double the number of prescriptions it fills each year through its existing in-house pharmacy,” the Ann Arbor-based system said March 15.&…

As the number of pharmacy residency program spots grow year over year, 4,980 people matched with 2,162 programs in the U.S., the American Society of Health-System Pharmacists said March 15.